Frequent genetic abnormalities of the PI3K/AKT pathway in primary ovarian cancer predict patient outcome

PI3K: a rational target for ovarian cancer therapy?

(2010) Paul Dent et al.   CANCER BIOLOGY & THERAPY

Identification of Candidate Growth Promoting Genes in Ovarian Cancer through Integrated Copy Number and Expression Analysis

(2010) Manasa Ramakrishna et al.   PLoS One

RNA Interference-Mediated Silencing of the Phosphatidylinositol 3-Kinase Catalytic Subunit Attenuates Growth of Human Ovarian Cancer Cells in vitroand in vivo

(2009) Xi Zhang et al.   ONCOLOGY

Mutations in the Phosphatidylinositol-3-Kinase Pathway Predict for Antitumor Activity of the Inhibitor PX-866 whereas Oncogenic Ras Is a Dominant Predictor for Resistance

(2008) N. T. Ihle et al.   CANCER RESEARCH

Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer

(2008) Saskia M. Wilting et al.   GENES CHROMOSOMES & CANCER

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

(2008) Roger McLendon et al.   NATURE